Metyrapone treatment in endogenous Cushings syndrome. Long term efficacy and safety results of the extension of the phase III/IV study PROMPT
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI